Artigos

Search for articles

BJO Oncology - Placeholder

Physiotherapy in the context of palliative care in oncology: a pooled analysis

ABSTRACT Objective: To document the role of physiotherapy in the context of palliative care in cancer through an integrative literature review, as the prevalence and survival of cancer are increasing and physiotherapy can significantly contribute to the treatment of these patients. Methods: A search was made in the literature for scientific articles...
BJO Oncology - Placeholder

Immune and targeted therapy for cancer: time to rethink restrictions for the treatment of the elderly and frail

ABSTRACT Targeted and immunotherapy have revolutionized cancer treatment. They safely substitute for traditional chemotherapy in a significant and growing number of malignancies. In this article, we review the United States Food and Drug Administration (FDA) - approved targeted and immunotherapies, currently used in oncology and compare their safety and efficacy...
BJO Oncology - Placeholder

Pharmacogenomic tests in Oncology - finding the right dose

ABSTRACT A pharmacogenetics/genomics (PGx) anticancer drug testing program is being developed by Kurtz and his group at the Brazilian National Cancer Institute (INCA). Drug -gene pairs were selected for PGx testing based on the presence of clinically validated PGx associations and the availability of international guidelines with PGx-informed dosing recommendations....
BJO Oncology - Placeholder

Pharmacogenomic tests of oncology drugs at Instituto Nacional de Câncer (INCA)

ABSTRACT The implementation, current status and future perspectives of the pharmacogenetics/genomics (PGx) testing program developed at Instituto Nacional de Cancer (INCA) are presented. Initial selection of drug-gene pairs for PGx testing was based on clinically-validated PGx associations and availability of international guidelines with PGx-informed dosing recommendations. The selected pairs were...
BJO Oncology - Placeholder

Patient reported outcome measure applicability in clinical oncology

ABSTRACT Patient Reported Outcomes (PROs) are a report that comes from patients on a specific subject, describing how they feel about a condition or therapy. The term includes a range of constructions and methodology and can cover concepts such as symptoms to physical assessment, well-being and social involvement. The process...
BJO Oncology - Placeholder

Patient's journey with HER2 positive breast cancer: difficulties in the access to treatment and new technologies in the Brazilian public health system

ABSTRACT Introduction:Many limitations in the Brazilian public health system make the patient's journey with HER2+ breast cancer and the access to better treatments hard. In the scenery in which all the economic resources of the country are limited, the right incorporation of the health technologies proves to be a challenge....
BJO Oncology - Placeholder

Challenges in the journey of breast cancer patients in Brazil

ABSTRACT The mortality rate of breast cancer (BC) in Brazil is increasing. Procedures that can improve the diagnosis and treatment of BC should be discussed by specialists to improve patient survival. Experts from five different specialties involved in the diagnosis and treatment of BC discussed possible problems and solutions in...
BJO Oncology - Placeholder

Metformin for the chemoprophylaxis of cancer: an update systematic review about the role of metformin in cancer prevention.

ABSTRACT Objective: Metformin has been evaluated as a possible molecule capable of preventing cancer. We performed a systematic review on this topic in 2014. However, since then, a plethora of studies has been conducted. Therefore we decided to undertake an updated systematic review. Methods: Systematic search in Medline from March 1st 2014...
BJO Oncology - Placeholder

Tracheostomy in suspected or confirmed cases of COVID-19

ABSTRACT The focus of this review is to present the consensus of head and neck surgery experts on tracheostomy during COVID-19 outbreak. Considerations about the ideal time to perform, surgical team, appropriate location, technique, and the necessary surgical equipment of the procedure were described to minimize risks of contamination of...
BJO Oncology - Placeholder

Brazilian consensus in muscle-invasive and metastatic urothelial carcinoma

ABSTRACT Urothelial carcinoma is a frequent worldwide malignancy. Poor survival rates in muscle-invasive and metastatic urothelial carcinoma impose major challenges for management. We conducted a consensus meeting to discuss the optimal treatment for urothelial carcinoma in Brazil, which was developed by a panel of multidisciplinary experts consisting of oncologists, urologists...